Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on “Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.”

Landi Doriana; Centonze Diego; Marfia Girolama Alessandra; Capra Ruggero; Scarpazza Cristina

首页> 外文期刊>Journal of clinical apheresis. >Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on “Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.”

【24h】

Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on “Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.”

机译：我们是否有足够的证据推荐与Natalizumab相关的渐进式多焦白血病患者的治疗性吸腹？评论“临床实践中临床实践中使用临床实践中的使用准则 - 来自美国阿马采法的书面审查委员会的循证方法：第七个特别问题。”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of clinical apheresis.》 |2018年第3期|共2页
作者
Landi Doriana; Centonze Diego; Marfia Girolama Alessandra; Capra Ruggero; Scarpazza Cristina;
展开▼
作者单位

Multiple Sclerosis Clinical and Research Unit Department of Systems MedicineTor Vergata;

Multiple Sclerosis Clinical and Research Unit Department of Systems MedicineTor Vergata;

Multiple Sclerosis Clinical and Research Unit Department of Systems MedicineTor Vergata;

Multiple Sclerosis Center Spedali Civili di BresciaMontichiari Brescia Italy;

Multiple Sclerosis Center Spedali Civili di BresciaMontichiari Brescia Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献

1. Clinical practice guideline dissemination and a new approach using Haddon matrix as a conceptual framework of evidence-based implementation strategies [J] . Peter Pang 世界急诊医学杂志(英文版) . 2010,第001期
2. Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on “Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.” [J] . Landi Doriana, Centonze Diego, Marfia Girolama Alessandra, Journal of clinical apheresis. . 2018,第3期

机译：我们是否有足够的证据推荐与Natalizumab相关的渐进式多焦白血病患者的治疗性吸腹？评论“临床实践中临床实践中使用临床实践中的使用准则 - 来自美国阿马采法的书面审查委员会的循证方法：第七个特别问题。”
3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue [J] . Padmanabhan Anand, Connelly‐Smith Laura, Aqui Nicole, Journal of clinical apheresis. . 2019,第3期

机译：临床实践中临床实践中使用治疗方法的准则 - 从美国阿草内撰写委员会的基于证据的方法：第八个特别问题
4. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. [J] . Szczepiorkowski ZM, Winters JL, Bandarenko N, Journal of clinical apheresis. . 2010,第3期

机译：在临床实践中使用治疗性血液分离术的指南-美国Apheresis协会Apheresis应用委员会的基于证据的方法。
5. Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review [O] . Leoni Rolfes, Steffen Pfeuffer, Tobias Ruck, 2019

机译：急性复发性多发性硬化症的治疗疗法：当前证据和未满足的需求—系统评价
6. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology [O] . Fuster Valentin, Rydén Lars E., Asinger Richard W., 2001

机译：ACC / AHA / ESC治疗房颤患者指南31该文件于2001年8月获得美国心脏病学会董事会，2001年8月美国心脏协会科学咨询与协调委员会以及欧洲心脏病学会的批准以及实践指南和政策委员会会议（2001年8月）。32引用本文件时，美国心脏病学会，美国心脏协会和欧洲心脏病学会将赞赏以下引用格式：Fuster V，RydénLE，Asinger RW，Cannom DS，Crijns HJ，Frye RL，Halperin JL，Kay GN，Klein WW，LévyS，McNamara RL，Prystowsky EN，Wann LS，Wyse DG。 ACC / AHA / ESC治疗房颤患者的指南：美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会和政策会议的报告（制定指南委员会）用于房颤患者的治疗）。 J Am Coll Cardiol 2001; 38：XX-XX.33本文件可在美国心脏病学会（www.acc.org），美国心脏协会（www.americanheart.org），欧洲的万维网站点上找到心脏病学会（www.escardio.org）和北美起搏和电生理学会（www.naspe.org）。可致电+44.207.424.4200或+44.207.424.4389，传真+44.207.424.4433或写信给Harcourt Publishers，以获取本文档（完整的准则）的单份重印本（完整的准则），该印刷本将于10月中旬出版。欧洲心脏杂志，ESC指南–转载，英国伦敦詹姆斯敦路32号，NW1 7BY。短版（执行摘要和建议摘要）的单版重印在《美国心脏病学会杂志》十月刊和《循环》十月刊上，致电800-253-4636（仅美国），每本售价5.00美元。）或写信给美国心脏病学院资源中心，地址是：马里兰州贝塞斯达市Old Georgetown Road 9111，邮编20814。要购买批量转载，请指定版本和转载编号（执行摘要71-0208；全文71-0209），最多999份，致电800-611-6083（仅限美国）或传真413-665-2671； 1000或更多副本，请致电214-706-1466，传真214-691-6342;或电子邮件：pubauth@heart.org。美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南和政策会议（制定房颤患者治疗指南委员会）的报告是与北方合作开发的美国起搏与电生理学会

著录项

相似文献

相关主题

期刊订阅